• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样蛋白PET自动定量的可靠性:商业工具相对于百分中心项目法的真实世界验证

Reliability of Automated Amyloid PET Quantification: Real-World Validation of Commercial Tools Against Centiloid Project Method.

作者信息

Kang Yeon-Koo, Min Jae Won, Kwon Soo Jin, Ha Seunggyun

机构信息

Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Division of Nuclear Medicine, Department of Radiology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.

出版信息

Tomography. 2025 Jul 30;11(8):86. doi: 10.3390/tomography11080086.

DOI:10.3390/tomography11080086
PMID:40863877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389775/
Abstract

Despite the growing demand for amyloid PET quantification, practical challenges remain. As automated software platforms are increasingly adopted to address these limitations, we evaluated the reliability of commercial tools for Centiloid quantification against the original Centiloid Project method. This retrospective study included 332 amyloid PET scans (165 [F]Florbetaben; 167 [F]Flutemetamol) performed for suspected mild cognitive impairments or dementia, paired with T1-weighted MRI within one year. Centiloid values were calculated using three automated software platforms, BTXBrain, MIMneuro, and SCALE PET, and compared with the original Centiloid method. The agreement was assessed using Pearson's correlation coefficient, the intraclass correlation coefficient (ICC), a Passing-Bablok regression, and Bland-Altman plots. The concordance with the visual interpretation was evaluated using receiver operating characteristic (ROC) curves. BTXBrain (R = 0.993; ICC = 0.986) and SCALE PET (R = 0.992; ICC = 0.991) demonstrated an excellent correlation with the reference, while MIMneuro showed a slightly lower agreement (R = 0.974; ICC = 0.966). BTXBrain exhibited a proportional underestimation (slope = 0.872 [0.860-0.885]), MIMneuro showed a significant overestimation (slope = 1.053 [1.026-1.081]), and SCALE PET demonstrated a minimal bias (slope = 1.014 [0.999-1.029]). The bias pattern was particularly noted for FMM. All platforms maintained their trends for correlations and biases when focusing on subthreshold-to-low-positive ranges (0-50 Centiloid units). However, all platforms showed an excellent agreement with the visual interpretation (areas under ROC curves > 0.996 for all). Three automated platforms demonstrated an acceptable reliability for Centiloid quantification, although software-specific biases were observed. These differences did not impair their feasibility in aiding the image interpretation, as supported by the concordance with visual readings. Nevertheless, users should recognize the platform-specific characteristics when applying diagnostic thresholds or interpreting longitudinal changes.

摘要

尽管对淀粉样蛋白PET定量的需求不断增长,但实际挑战依然存在。随着自动化软件平台越来越多地被采用来应对这些限制,我们针对原始的Centiloid项目方法评估了用于Centiloid定量的商业工具的可靠性。这项回顾性研究纳入了332例淀粉样蛋白PET扫描(165例使用[F]氟代苯并噻唑;167例使用[F]氟代甲磺酸美金刚),这些扫描是针对疑似轻度认知障碍或痴呆进行的,并在一年内与T1加权MRI配对。使用三种自动化软件平台BTXBrain、MIMneuro和SCALE PET计算Centiloid值,并与原始的Centiloid方法进行比较。使用Pearson相关系数、组内相关系数(ICC)、Passing-Bablok回归和Bland-Altman图评估一致性。使用受试者操作特征(ROC)曲线评估与视觉解读的一致性。BTXBrain(R = 0.993;ICC = 0.986)和SCALE PET(R = 0.992;ICC = 0.991)与参考值显示出极好的相关性,而MIMneuro的一致性略低(R = 0.974;ICC = 0.966)。BTXBrain表现出成比例的低估(斜率 = 0.872 [0.860 - 0.885]),MIMneuro显示出显著高估(斜率 = 1.053 [1.026 - 1.081]),SCALE PET表现出最小偏差(斜率 = 1.014 [0.999 - 1.029])。FMM的偏差模式尤为明显。当关注亚阈值到低阳性范围(0 - 50 Centiloid单位)时,所有平台在相关性和偏差方面都保持了各自的趋势。然而,所有平台与视觉解读都显示出极好的一致性(所有平台的ROC曲线下面积> 0.996)。三个自动化平台在Centiloid定量方面表现出可接受的可靠性,尽管观察到了软件特定的偏差。这些差异并不影响它们在辅助图像解读方面的可行性,视觉读数的一致性也证明了这一点。尽管如此,用户在应用诊断阈值或解释纵向变化时应认识到平台特定的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/b125068674f6/tomography-11-00086-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/c814fb00d645/tomography-11-00086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/a6008af2fda9/tomography-11-00086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/3fa63c291f73/tomography-11-00086-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/1d346cf8cb66/tomography-11-00086-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/00b99fd5a072/tomography-11-00086-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/b125068674f6/tomography-11-00086-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/c814fb00d645/tomography-11-00086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/a6008af2fda9/tomography-11-00086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/3fa63c291f73/tomography-11-00086-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/1d346cf8cb66/tomography-11-00086-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/00b99fd5a072/tomography-11-00086-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3de3/12389775/b125068674f6/tomography-11-00086-g006.jpg

相似文献

1
Reliability of Automated Amyloid PET Quantification: Real-World Validation of Commercial Tools Against Centiloid Project Method.淀粉样蛋白PET自动定量的可靠性:商业工具相对于百分中心项目法的真实世界验证
Tomography. 2025 Jul 30;11(8):86. doi: 10.3390/tomography11080086.
2
Consistency Analysis of Centiloid Values Across Three Commercial Software Platforms for Amyloid PET Quantification.三种用于淀粉样蛋白PET定量分析的商业软件平台的百分克氏单位值一致性分析
Diagnostics (Basel). 2025 Jun 24;15(13):1599. doi: 10.3390/diagnostics15131599.
3
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
4
Comparison of Amyloid-PET Analysis Software Using F-Florbetaben PET in Patients with Cognitive Impairment.使用¹⁸F-氟贝他宾PET对认知障碍患者进行淀粉样蛋白PET分析软件的比较。
Diagnostics (Basel). 2025 Aug 13;15(16):2028. doi: 10.3390/diagnostics15162028.
5
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
6
Non-standard pipeline without MRI has replicability in computation of Centiloid scale values for PiB and F-labeled amyloid PET tracers.没有MRI的非标准流程在计算PiB和F标记淀粉样蛋白PET示踪剂的Centiloid量表值方面具有可重复性。
Neuroimage Rep. 2022 May 21;2(3):100101. doi: 10.1016/j.ynirp.2022.100101. eCollection 2022 Sep.
7
(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).(11)使用C-PIB-PET对轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆进行早期诊断。
Cochrane Database Syst Rev. 2014 Jul 23;2014(7):CD010386. doi: 10.1002/14651858.CD010386.pub2.
8
Is 18 F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?18F-氟化物PET/CT是诊断全关节置换术后假体松动的准确工具吗?
Clin Orthop Relat Res. 2025 Mar 1;483(3):415-428. doi: 10.1097/CORR.0000000000003228. Epub 2024 Sep 11.
9
Concordance Between Amyloid-PET Quantification and Real-World Visual Reads.淀粉样蛋白PET定量与实际视觉读数之间的一致性
JAMA Neurol. 2025 Jul 28. doi: 10.1001/jamaneurol.2025.2218.
10
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.

本文引用的文献

1
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.淀粉样蛋白和tau蛋白PET的更新后合理使用标准:阿尔茨海默病协会与核医学和分子影像学会工作组的报告
Alzheimers Dement. 2025 Jan;21(1):e14338. doi: 10.1002/alz.14338. Epub 2025 Jan 8.
2
Centiloid recommendations for clinical context-of-use from the AMYPAD consortium.AMYPAD联盟关于临床使用背景的Centiloid建议。
Alzheimers Dement. 2024 Dec;20(12):9037-9048. doi: 10.1002/alz.14336. Epub 2024 Nov 20.
3
A Comparative Analysis of Two Automated Quantification Methods for Regional Cerebral Amyloid Retention: PET-Only and PET-and-MRI-Based Methods.
两种基于 PET 和 PET-MRI 的区域脑淀粉样蛋白保留自动量化方法的比较分析。
Int J Mol Sci. 2024 Jul 12;25(14):7649. doi: 10.3390/ijms25147649.
4
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.修订的阿尔茨海默病诊断和分期标准:阿尔茨海默病协会工作组。
Alzheimers Dement. 2024 Aug;20(8):5143-5169. doi: 10.1002/alz.13859. Epub 2024 Jun 27.
5
Anti-amyloid Antibody Therapies for Alzheimer's Disease.用于阿尔茨海默病的抗淀粉样蛋白抗体疗法
Nucl Med Mol Imaging. 2024 Jun;58(4):227-236. doi: 10.1007/s13139-024-00848-3. Epub 2024 Feb 20.
6
Clinical Performance Evaluation of an Artificial Intelligence-Powered Amyloid Brain PET Quantification Method.一种人工智能驱动的淀粉样蛋白脑PET定量方法的临床性能评估
Nucl Med Mol Imaging. 2024 Jun;58(4):246-254. doi: 10.1007/s13139-024-00861-6. Epub 2024 May 2.
7
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.在 Centiloids 中探究可靠的淀粉样蛋白沉积:来自 AMYPAD 预后和自然史研究的结果。
Alzheimers Dement. 2024 May;20(5):3429-3441. doi: 10.1002/alz.13761. Epub 2024 Apr 4.
8
Quantitative Brain Amyloid PET.定量脑淀粉样 PET。
J Nucl Med. 2024 May 1;65(5):670-678. doi: 10.2967/jnumed.123.265766.
9
Comparison of consistency in centiloid scale among different analytical methods in amyloid PET: the CapAIBL, VIZCalc, and Amyquant methods.不同分析方法在淀粉样 PET 中的百分位尺度一致性比较:CapAIBL、VIZCalc 和 Amyquant 方法。
Ann Nucl Med. 2024 Jun;38(6):460-467. doi: 10.1007/s12149-024-01919-3. Epub 2024 Mar 21.
10
Biomarker-based staging of Alzheimer disease: rationale and clinical applications.基于生物标志物的阿尔茨海默病分期:原理与临床应用。
Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1.